CONMED CORPORATION Current Income Tax Expense (Benefit)
CONMED CORPORATION (CNMD) reported Current Income Tax Expense (Benefit) of $20.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-17
- CONMED CORPORATION current income tax expense (benefit) for fiscal 2025 was $20.54M, a 11.60% increase from fiscal 2024.
- CONMED CORPORATION current income tax expense (benefit) for fiscal 2024 was $18.40M, a 17.45% increase from fiscal 2023.
- CONMED CORPORATION current income tax expense (benefit) for fiscal 2023 was $15.67M, a 0.59% decline from fiscal 2022.
- CONMED CORPORATION current income tax expense (benefit) for fiscal 2022 was $15.76M, a 108.55% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $20.54M 10-K · filed 2026-02-17 |
| 2024-12-31 | $18.40M 10-K · filed 2026-02-17 |
| 2023-12-31 | $15.67M 10-K · filed 2026-02-17 |
| 2022-12-31 | $15.76M 10-K · filed 2025-02-18 |
| 2021-12-31 | $7.56M 10-K · filed 2024-02-28 |
| 2020-12-31 | $6.32M 10-K · filed 2023-02-21 |
| 2019-12-31 | $8.91M 10-K · filed 2022-02-22 |
| 2018-12-31 | $7.74M 10-K · filed 2021-02-22 |
| 2017-12-31 | $13.27M 10-K · filed 2020-02-24 |
| 2016-12-31 | $7.58M 10-K · filed 2019-02-25 |
| 2015-12-31 | $12.39M 10-K · filed 2018-02-26 |
| 2014-12-31 | $14.77M 10-K · filed 2017-02-27 |
| 2013-12-31 | $7.47M 10-K · filed 2016-02-23 |
| 2012-12-31 | $6.05M 10-K · filed 2015-02-23 |
| 2011-12-31 | $10.04M 10-K · filed 2014-02-24 |
| 2010-12-31 | $2.15M 10-K · filed 2013-02-25 |
| 2009-12-31 | $1.78M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |